Author

F.-Y. Lin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Bioengineering· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:cell signaling & trafficking· 2 Research Focus:cell type annotation· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

A. Bourgeois· 1 shared A. Chavez· 1 shared A. McTeague· 1 shared A. Pelletier· 1 shared A. S. Ray· 1 shared A. Zask· 1 shared B. Goodwin· 1 shared B. Lippa· 1 shared

Activity by Year

2018-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

A. Bourgeois

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights from Comprehensive Multicenter Preclinical Studies

S.-E. Lemay, M. S. Montesinos, Y. Grobs, T. Yokokawa, T. Shimauchi, C. Romanet, M. Sauvaget, S. Breuils-Bonnet, A. Bourgeois, C. Theberge, A. Pelletier, R. El Kabbout, S. Martineau, K. Yamamoto, A. S. Ray, , S. Bonnet

The study identifies integrin α5β1 as a key driver of pulmonary vascular remodeling in PAH and shows its inhibition improves hemodynamics and RV function in preclinical models.

bioRxiv · May 27, 2024Pathology

Dissolvable microgel-templated macroporous hydrogels for controlled cell assembly

Z. Jiang, F.-Y. Lin, K. Jiang, H. Nguyen, C.-Y. Chang, C.-C. Lin

This paper develops a method to create cell-laden macroporous hydrogels using dissolvable microgels, enabling controlled cell assembly and secretion of growth factors.

bioRxiv · Jan 5, 2022Bioengineering

Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors

S. Iketani, F. Forouhar, H. Liu, S. J. Hong, F.-Y. Lin, M. S. Nair, A. Zask, Y. Huang, L. Xing, B. R. Stockwell, A. Chavez, D. D. Ho

The paper identifies three structurally diverse compounds as inhibitors of the SARS-CoV-2 3CL protease and provides structural insights for inhibitor design.

bioRxiv · Aug 3, 2020Microbiology

Adenosine Deaminase Acting on RNA 1 Associates with Orf Virus OV20.0 and Enhances Viral Replication

G.-R. Liao, Y.-Y. Tseng, J.-Y. Tseng, F.-Y. Lin, Y. Yamada, H.-P. Liu, C.-Y. Kuan, W.-L. Hsu

This study identifies a novel interaction between ORFV protein OV20.0 and ADAR1, showing OV20.0 suppresses ADAR1's A-to-I editing and enhances viral replication by inhibiting PKR phosphorylation.

bioRxiv · Nov 1, 2018Microbiology